HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

AZD3839

a BACE1 inhibitor; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - AZD3839: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - AZD3839: 2

Experts

1.	Eketjäll, Susanna: 2 articles (11/2012 - 11/2012)
2.	Fälting, Johanna: 2 articles (11/2012 - 11/2012)
3.	Janson, Juliette: 2 articles (11/2012 - 11/2012)
4.	Jeppsson, Fredrik: 2 articles (11/2012 - 11/2012)
5.	Karlström, Sofia: 2 articles (11/2012 - 11/2012)
6.	Kolmodin, Karin: 2 articles (11/2012 - 11/2012)
7.	Olsson, Lise-Lotte: 2 articles (11/2012 - 11/2012)
8.	Swahn, Britt-Marie: 2 articles (11/2012 - 11/2012)
9.	von Berg, Stefan: 2 articles (11/2012 - 11/2012)
10.	Bueters, Tjerk: 1 article (11/2012)

Related Diseases

1.

Alzheimer Disease (Alzheimer's Disease)

11/30/2012 - "Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease."
11/08/2012 - "The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clinical candidate drug for Alzheimer's disease, (S)-32 (AZD3839), are described. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Enzymes
3.	Amyloid (Amyloid Fibrils)